Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ISRADIPINE vs ITACITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ISRADIPINE vs ITACITINIB: Safety Overview

Metric ISRADIPINE ITACITINIB
Total FAERS Reports 119 216
Deaths Reported 14 39
Death Rate 11.8% 18.1%
Hospitalizations 72 187
Average Patient Age 55.5 yrs 55.0 yrs
% Female Patients 46.3% 33.2%
FDA Approval Date Apr 24, 2006 N/A
Manufacturer Teva Pharmaceuticals USA, Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A